Granite Point Capital Management, L.P. Arcturus Therapeutics Holdings Inc. Transaction History

Granite Point Capital Management, L.P.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 05, 2021	SELL	$34.61 - $123.66 $3.46 Million - $12.4 Million	-100,000 Closed	0 $0
Q3 2020 Nov 06, 2020	BUY	$37.49 - $63.19 $1.87 Million - $3.16 Million	50,000 Added 100.0%	100,000 $4.29 Million
Q2 2020 Aug 12, 2020	BUY	$12.66 - $58.27 $633,000 - $2.91 Million	50,000 New	50,000 $2.34 Million

179

25.6M

195K

133K

Ticker ARCT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 26,576,400
Market Cap $439M
Description
Arcturus Therapeutics Holdings Inc., an RNA medicines company, focuses on the development of vaccines for infectious, and liver and respiratory rare diseases in the United States. The company's development programs comprise LUNAR-OTC development program for ornithine transcarbamylase (OTC) deficiency; and LUNAR-CF program for cystic fibrosis lun...

Get notified when there are updates to the investment portfolio of Granite Point Capital Management, L.P., based on Form 13F filings with the SEC.

Stay updated on Granite Point Capital Management, L.P. with notifications on news.